2021
Management of Pediatric Graves Disease
Quintanilla-Dieck L, Khalatbari HK, Dinauer CA, Rastatter JC, Chelius DC, Katowitz WR, Shindo ML, Parisi MT, Kazahaya K. Management of Pediatric Graves Disease. JAMA Otolaryngology - Head & Neck Surgery 2021, 147: 1110-1118. PMID: 34647991, DOI: 10.1001/jamaoto.2021.2715.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsGraves' diseaseClinical presenting signsPediatric Graves' diseaseSustained remission rateRadioactive iodine therapyFirst-line treatmentSpecific clinical characteristicsMultidisciplinary approachIodine therapyRemission rateClinical characteristicsDefinitive treatmentMedical therapyPediatric patientsPresenting signMedical managementPediatric populationAntithyroid drugsTherapeutic optionsCertain patientsTreatment optionsOptimal treatmentThyroid ultrasonographyPediatric expertsNuclear medicine
2009
Chapter 98 The Use of 131Iodine in the Treatment of Graves’ Disease in Children
Rivkees S, Dinauer C. Chapter 98 The Use of 131Iodine in the Treatment of Graves’ Disease in Children. 2009, 942-955. DOI: 10.1016/b978-0-12-374135-6.00098-4.ChaptersGraves' diseaseRadioactive iodineThyroid cancerSide effectsLong-term adverse side effectsLong-term remission ratesRecurrent laryngeal nerve paresisPreferred definitive treatmentTreatment of GravesAcute side effectsBone marrow suppressionLaryngeal nerve paresisLong-term complicationsSerious adverse reactionsCurrent treatment optionsHigh cure ratesLarge thyroid glandForm of surgeryAdverse side effectsGenetic damageAntithyroid medicationDefinitive therapyNerve paresisPermanent hypoparathyroidismRemission rate